Search filters

List of works by Jens Siveke

A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling

scientific article published on 19 January 2015

Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia

scientific article published on 13 October 2020

Cellular model system to dissect the isoform-selectivity of Akt inhibitors

scientific article published on 06 September 2021

Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma

scientific article published on 29 June 2020

Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer

scientific article published on 23 September 2016

Covalent-Allosteric Inhibitors to Achieve Akt Isoform-Selectivity

scientific article published on 08 November 2019

Direct Molecular Tissue Analysis by MALDI Imaging Mass Spectrometry in the Field of Gastrointestinal Disease

scientific article published on July 20, 2012

Epigenetics of gastrointestinal diseases: notes from a workshop

scientific article published on 30 July 2018

Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma

scientific article published on 07 March 2020

N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma

scientific article published on 28 April 2020

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer

scientific article published on 11 March 2019

Proton Irradiation Increases the Necessity for Homologous Recombination Repair Along with the Indispensability of Non-Homologous End Joining

scientific article published on 05 April 2020

Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience

scientific article

Surgery for cystic pancreatic lesions in the post-sendai era: a single institution experience

scientific article

TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer

scientific article published on 11 March 2020

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma

scientific article published on 04 May 2020